As the National Institutes of Health has noted, “neurologists are beginning to see that brain diseases are more prevalent than ever before.”
But what is it about the brain that makes some of us more prone to brain disease, and why does the condition cause so much suffering?
According to the National Institute of Neurological Disorders and Stroke (NINDS), approximately 40% of people with ALS have a genetic or environmental vulnerability to the disease, which can lead to a myriad of cognitive problems including problems with attention, memory, executive functioning, and learning and memory.
As such, a diagnosis of ALS is often a matter of finding out whether your family members or friends have the same problem.
If your family member or friends do have ALS, the chances are that the disease is genetic, and that they are at high risk for developing it.
In addition, the NINDS estimates that more than 40% (more than 15 million people) of people living with ALS suffer from some form of neurodegenerative disorder (NDD).
These conditions can be asymptomatic, asymplastic, and progressive, and can cause the death of brain cells and other organs in the body.
The NINHS estimates that nearly one in every eight people with a neurodegenative disorder will die of the disease.
It’s not just about the disease itself, either.
Many people have symptoms of ALS before the disease sets in, but this is often not obvious, so the disease may remain undetected.
This is especially true if symptoms are mild, and are seen in the late stages of the illness, like when symptoms are present at a low level.
In many cases, the symptoms may be mild and not appear until the disease starts to set in.
These are the people who are most likely to develop ALS: People with genetic susceptibility to ALS are at risk for the disease and have a higher chance of developing it early in life.
People with a low genetic risk for ALS are also at risk of developing the disease later in life, but it takes a long time to develop a brain disease.
For example, people with genetic predisposition to ALS who have a history of hearing loss may develop the disease in their early 20s or 30s, but symptoms may not be noticeable until the age of 60 or later.
In fact, the only people at higher risk for Alzheimer’s disease are people with family members with ALS.
The symptoms that are seen early in the disease can be mild, but the disease takes a lifetime to set into.
People who are at low genetic risks are more likely to have hearing loss, but not hearing problems as a whole.
People at higher genetic risk are more prone than others to developing other neurodegeners, including brain and spinal cord injuries, stroke, and certain cancers.
People living with a family history of ALS have lower rates of the neurodegendering disorders that are common among those with the disease (such as amyotrophoblastic leukemia and progressive multifocal leukoencephalopathy).
The NINCDS estimates, for example, that between 20 and 40% in the U.S. have a familial history of dementia or Alzheimer’s.
People diagnosed with ALS can have a high risk of other neuro-degeneration.
They are more susceptible to other neurological disorders, including epilepsy, attention deficit hyperactivity disorder, and traumatic brain injury.
People have lower odds of developing certain neurological conditions including Alzheimer’s, Parkinson’s, Huntington’s disease, multiple sclerosis, and amyotrophy.
In terms of the risk of dementia and Alzheimer’s and other neuropsychiatric disorders, the odds are low.
In other words, people diagnosed with Alzheimer’s can have normal life spans.
People on long-term treatment with a medication to control seizures are less likely to be diagnosed with dementia and other neurological diseases, and their risk of development of those diseases is lower than the risk in people who do not take medications.
But the fact that there is an increase in ALS-related disease in people with long-standing disease does not necessarily mean that these patients are at a higher risk of the diseases.
The same is true for people with some forms of dementia.
In these cases, people who have been diagnosed with the neuro-psychiatric condition do not have an increased risk of having a neuro-developmental disorder or other neurological disorder, as has been reported in the past.
This means that people with the risk factors for the neuropsychiatry or other neurodevelopmental disorders are at reduced risk of brain disease as a result of their long-held neurological condition.
In short, a person diagnosed with a genetic vulnerability to ALS can develop dementia or develop other neurodisorders that are less severe than the diseases that people without a genetic susceptibility for ALS would develop.
The number of people in the United States with ALS and other neurologic conditions is